Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
Recruiting · NCT00899405 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of California, Davis
View the official record on ClinicalTrials.gov →What this trial is about
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Eligibility criteria (as published)
DISEASE CHARACTERISTICS:
* Histologically or cytologically confirmed lung cancer
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* May have received prior EGFR inhibitors
Where it is running
1 location listed across 1 US state.
- University of California Davis Cancer Center - Sacramento, California, United States